Some Drugs and Herbal Products
Publisher: International Agency for Research on Cancer 2016
Number of pages: 438
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).
Home page url
Download or read it online for free here:
- National Academies Press
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer and considers innovative, sustainable research collaborations ...
by Kimberly K Vesco, et al. - Agency for Healthcare Research
This systematic review of cervical cancer screening focuses on when to begin screening and on updating test accuracy and harms data on liquid-based cytology (LBC) and human papillomavirus (HPV) testing, either alone or in combination with cytology.
by James F. Holland, at al. - B.C. Decker
A reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. The book covers the ever-widening sphere of current cancer knowledge and clinical practice.
by Alecsandru Ioan Baba, Cornel Catoi - Romanian Academy
Comparative oncology has undergone a special development over the past decades and has attracted the interest of researchers who have studied the etiopathogenesis, morphogenesis and epidemiology, as well as the carcinogens of tumor disease.